GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Novo Nordisk (NVO) and Eli Lilly & Co. (NYSE:LLY), the global leaders in obesity medications, are now facing their first ...

The weight loss drug market in China is expected to boom in the coming years. A government report from late 2020 said more than 50% of adults in China were overweight, which is defined as having a ...

Large Chinese drug networks are helping fuel the U.S. fentanyl crisis, a situation Beijing has little incentive to combat amid deteriorating relations with Washington. "Since approximately 2013 ...

When his store does manage to get hold of some supply, he is able to provide delivery to longstanding customers in China through a complex process that takes about two weeks, costing between HK ...

An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...

A drug that outperforms placebo in helping people to lose weight is one of a growing number of next-generation obesity drugs being produced in China. At first, Chinese pharmaceutical companies rushed ...

Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the quality of medicine. By Alexandra Stevenson and Zixu Wang Reporting from ...

Public hospitals account for about 70 percent of China’s drug market. Patients who use private clinics have easier access to a wider choice of medication, including foreign brands.